microdosed tirzepatide Microdosing Microdosed Tirzepatide
Description
Sharing a 94% structural homology with native human GLP-1, Semaglutide is distinguished by three modifications: 1) amino-acid substitutions at position 8 (alanine to -aminoisobutyric acid or Aib) and position 34 (lysine to arginine), and acylation of the lysine in position 26 with a spacer consisting of two 8-amino-3,6-dioxaoctanoic acid (ADO) moieties, a glutamic acid moiety, and a C-18 fatty di-acid side chain (Lau et al., 2015)

Jorsal A, Kistorp C, Holmager P, Tougaard RS, Nielsen R, Hnselmann A, et al

Phillips LK, Deane AM, Jones KL, Rayner CK, Horowitz M

I felt amazing, I looked amazing, Wilson told USA Today last September about Nooms microdose GLP-1
